T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Am J Hematol
; 99(3): 494-496, 2024 Mar.
Article
em En
| MEDLINE
| ID: mdl-38240336
ABSTRACT
Survival remains poor for T-cell prolymphocytic leukemia, though treatment in recent years, associated with access to novel therapies, and management at academic medical centers is associated with improved outcomes. There remains a critical need to improve the available treatment options for this population, and access to specialized academic medical centers, comprehensive supportive care, clinical trials, and early palliative care remains essential for T-PLL patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Leucemia Prolinfocítica de Células T
/
Transplante de Células-Tronco Hematopoéticas
Tipo de estudo:
Screening_studies
Limite:
Humans
Idioma:
En
Revista:
Am J Hematol
Ano de publicação:
2024
Tipo de documento:
Article